TrialDiabetes, obesity & metabolism2018

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study.

Serge A Jabbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.